Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GANDHI, Leena")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 9 of 9

  • Page / 1
Export

Selection :

  • and

Crizotinib for ALK-Rearranged Non―Small Cell Lung Cancer: A New Targeted Therapy for a New TargetGANDHI, Leena; JÄNNE, Pasi A.Clinical cancer research (Print). 2012, Vol 18, Num 14, pp 3737-3742, issn 1078-0432, 6 p.Article

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancerGANDHI, Leena; HARDING, Matthew W; NEUBAUER, Marcus et al.Cancer. 2007, Vol 109, Num 5, pp 924-932, issn 0008-543X, 9 p.Article

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid TumorsGANDHI, Leena; CAMIDGE, D. Ross; DIVE, Caroline et al.Journal of clinical oncology. 2011, Vol 29, Num 7, pp 909-916, issn 0732-183X, 8 p.Article

Collagen XXIII: A Potential Biomarker for the Detection of Primary and Recurrent Non―Small Cell Lung CancerSPIVEY, Kristin A; BANYARD, Jacqueline; SOLIS, Luisa M et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 5, pp 1362-1372, issn 1055-9965, 11 p.Article

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to GefitinibENGELMAN, Jeffrey A; ZEJNULLAHU, Kreshnik; ALTHAUS, Irene W et al.Cancer research (Baltimore). 2007, Vol 67, Num 24, pp 11924-11932, issn 0008-5472, 9 p.Article

Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group StudySHIBATA, Stephen I; CHUNG, Vincent; O'NEIL, Bert H et al.Clinical cancer research (Print). 2013, Vol 19, Num 13, pp 3631-3639, issn 1078-0432, 9 p.Article

Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2―Dependent and Other Solid TumorsGANDHI, Leena; BAHLEDA, Rastislav; KRYGOWSKI, Mizue et al.Journal of clinical oncology. 2014, Vol 32, Num 2, pp 68-75, issn 0732-183X, 8 p.Article

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung CancerRUDIN, Charles M; HANN, Christine L; RANSON, Malcolm R et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3163-3169, issn 1078-0432, 7 p.Article

Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung CancerKWAK, Eunice L; BANG, Yung-Jue; VARELLA-GARCIA, Marileila et al.The New England journal of medicine. 2010, Vol 363, Num 18, pp 1693-1703, issn 0028-4793, 11 p.Article

  • Page / 1